Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bilodeau

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2024
CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentationNatalia Drosu, Monique Anderson, Philippe A Bilodeau, et al.
Organic Letters|September 30, 2015
Formaldehyde as Tethering Organocatalyst: Highly Diastereoselective Hydroaminations of Allylic AminesColin R Hesp, Melissa J MacDonald, M Mehdi Zahedi, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|March 8, 2014
Evaluation of SOX2 as a potential marker for ameloblastic carcinomaYu Lei, Jumana M Jaradat, Adepitan Owosho, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2019
MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum settingPhilippe A Bilodeau, Vinayak Kumar, Andrew E Rodriguez, et al.
JAMA Neurology|January 5, 2026
Early Relapse Risk in Biopsy-Confirmed Primary Central Nervous System VasculitisJames V Nguyen, Phillippe A Bilodeau, João Vitor Mahler, et al.
Journal of the Neurological Sciences|February 9, 2024
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, et al.
The Journal of Infectious Diseases|January 6, 2026
A threshold in anti-EBNA-1 antibody titers distinguishes salivary EBV shedders from non-sheddersJoão Vitor Mahler, Philippe A Bilodeau, Monique Anderson, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Neuropsychologic impact of MOGAD: A patient reported outcomes studyBruna Leles, Yihan Zhang, Philippe A Bilodeau, et al.
Journal of the American Chemical Society|July 9, 2024
Accelerating Computational Materials Discovery with Machine Learning and Cloud High-Performance Computing: from Large-Scale Screening to Experimental ValidationChi Chen, Dan Thien Nguyen, Shannon J Lee, et al.
Histopathology|March 25, 2016
A subset of ectomesenchymal chondromyxoid tumours of the tongue show EWSR1 rearrangements and are genetically linked to soft tissue myoepithelial neoplasms: a study of 11 casesProkopios P Argyris, Elizabeth A Bilodeau, Aaron E Yancoskie, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2024
CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentationNatalia Drosu, Monique Anderson, Philippe A Bilodeau, et al.
Organic Letters|September 30, 2015
Formaldehyde as Tethering Organocatalyst: Highly Diastereoselective Hydroaminations of Allylic AminesColin R Hesp, Melissa J MacDonald, M Mehdi Zahedi, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|March 8, 2014
Evaluation of SOX2 as a potential marker for ameloblastic carcinomaYu Lei, Jumana M Jaradat, Adepitan Owosho, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2019
MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum settingPhilippe A Bilodeau, Vinayak Kumar, Andrew E Rodriguez, et al.
JAMA Neurology|January 5, 2026
Early Relapse Risk in Biopsy-Confirmed Primary Central Nervous System VasculitisJames V Nguyen, Phillippe A Bilodeau, João Vitor Mahler, et al.
Journal of the Neurological Sciences|February 9, 2024
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, et al.
The Journal of Infectious Diseases|January 6, 2026
A threshold in anti-EBNA-1 antibody titers distinguishes salivary EBV shedders from non-sheddersJoão Vitor Mahler, Philippe A Bilodeau, Monique Anderson, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Neuropsychologic impact of MOGAD: A patient reported outcomes studyBruna Leles, Yihan Zhang, Philippe A Bilodeau, et al.
Journal of the American Chemical Society|July 9, 2024
Accelerating Computational Materials Discovery with Machine Learning and Cloud High-Performance Computing: from Large-Scale Screening to Experimental ValidationChi Chen, Dan Thien Nguyen, Shannon J Lee, et al.
Histopathology|March 25, 2016
A subset of ectomesenchymal chondromyxoid tumours of the tongue show EWSR1 rearrangements and are genetically linked to soft tissue myoepithelial neoplasms: a study of 11 casesProkopios P Argyris, Elizabeth A Bilodeau, Aaron E Yancoskie, et al.
Pageof 13